MAFG and prostate carcinoma: To evaluate the expression of MAFG-AS1 in prostate cancer, we compared MAFG-AS1 expression in 495 prostate cancer and 50 adjacent normal tissues, and the results suggested that MAFG-AS1 was upregulated in prostate cancer (Figure 1A).